Bellicum Pharmaceuticals Inc

NASDAQ:BLCM   3:59:51 PM EDT
1.36
0.00 (+0.37%)
Earnings Announcements

Bellicum Reports Fourth Quarter 2021 Results

Published: 03/24/2022 20:17 GMT
Bellicum Pharmaceuticals Inc (BLCM) - Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Update.
Bellicum Pharmaceuticals Inc- Reported Cash and Cash Equivalents and Restricted Cash Totaling $47.7 Million As of December 31, 2021.
Bellicum Pharmaceuticals Inc- Expects That Current Cash Resources Will Be Sufficient to Meet Operating Requirements Into Q2 of 2023.
Bellicum Pharmaceuticals Inc- Reported Revenue of $0.5 Million for Q4.
Bellicum Pharmaceuticals Inc - Qtrly Earnings per Share $0.11.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.71

More details on our Analysts Page.